Cha Hospital announced that David Pépin, a professor at Harvard Medical School, has been awarded the 13th KY Cha Award in Reproductive Medicine during the 82nd Annual Meeting of the American Society for Reproductive Medicine (ASRM) held at the Baltimore Convention Center in Maryland on October 28.
The KY Cha Award was established in 2011 by the ASRM to honor the contributions of Cha Kwang-ryul, the director of the Global Comprehensive Research Institute at Cha Hospital and Cha Bio Group, in the fields of infertility treatment and stem cell and regenerative medicine. It is the only award named after an Asian by the ASRM, presented to researchers who have made innovative contributions in reproductive medicine and infertility. To date, 14 physicians and scientists from prestigious institutions such as Harvard University, Cornell University, and the National Institutes of Health (NIH) have received this award.
Professor Pépin received the award for his research titled 'Extrafollicular Ovarian Steroidogenesis: Stromal Hormone Production as a Therapeutic Target in Ovarian Aging.' The ovaries are responsible for maturing eggs and producing female hormones such as estrogen. A decline in ovarian function due to aging can affect reproductive ability and overall health in women.
Pépin focused on the hormone production function of ovarian stromal cells, which are tissues outside the follicles, during the ovarian aging process. He proposed this as a new therapeutic target for addressing ovarian aging. His research moves beyond the traditional focus on follicles and eggs to examine the roles of various cells that make up the ovaries, contributing to a better understanding of the mechanisms of ovarian aging and strategies to counteract diminished ovarian function.
Meanwhile, Director Cha has expanded research from reproductive medicine to stem cell and regenerative medicine, continuing to build research infrastructure, nurture talent, and support researchers. Recently, he has been giving lectures domestically and internationally on 'K-Cell' and 'Longevity,' sharing visions for extending healthy lifespans and the future of medicine through stem cells and regenerative therapies.
Director Cha is also committed to establishing academic awards and supporting researchers to advance reproductive medicine and stem cell and regenerative medicine. Awards named after him are not only operated by the ASRM but also by the Korean Society for Stem Cell Research and the Korean Society for Reproductive Medicine. The Asian Cell Therapy Organization (ACTO) also recognizes outstanding researchers through the 'Cha Kwang-ryul Excellence Presentation Award.'
The KY Cha Award was established in 2011 by the ASRM to honor the contributions of Cha Kwang-ryul, the director of the Global Comprehensive Research Institute at Cha Hospital and Cha Bio Group, in the fields of infertility treatment and stem cell and regenerative medicine. It is the only award named after an Asian by the ASRM, presented to researchers who have made innovative contributions in reproductive medicine and infertility. To date, 14 physicians and scientists from prestigious institutions such as Harvard University, Cornell University, and the National Institutes of Health (NIH) have received this award.
Professor Pépin received the award for his research titled 'Extrafollicular Ovarian Steroidogenesis: Stromal Hormone Production as a Therapeutic Target in Ovarian Aging.' The ovaries are responsible for maturing eggs and producing female hormones such as estrogen. A decline in ovarian function due to aging can affect reproductive ability and overall health in women.
Pépin focused on the hormone production function of ovarian stromal cells, which are tissues outside the follicles, during the ovarian aging process. He proposed this as a new therapeutic target for addressing ovarian aging. His research moves beyond the traditional focus on follicles and eggs to examine the roles of various cells that make up the ovaries, contributing to a better understanding of the mechanisms of ovarian aging and strategies to counteract diminished ovarian function.
Meanwhile, Director Cha has expanded research from reproductive medicine to stem cell and regenerative medicine, continuing to build research infrastructure, nurture talent, and support researchers. Recently, he has been giving lectures domestically and internationally on 'K-Cell' and 'Longevity,' sharing visions for extending healthy lifespans and the future of medicine through stem cells and regenerative therapies.
Director Cha is also committed to establishing academic awards and supporting researchers to advance reproductive medicine and stem cell and regenerative medicine. Awards named after him are not only operated by the ASRM but also by the Korean Society for Stem Cell Research and the Korean Society for Reproductive Medicine. The Asian Cell Therapy Organization (ACTO) also recognizes outstanding researchers through the 'Cha Kwang-ryul Excellence Presentation Award.'
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.